Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270866 · ClinicalTrials.gov registry record · NA
Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia
A NA study, sponsored by Scion NeuroStim.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02270866 is a NA study that has completed, run by Scion NeuroStim. The registered enrollment target is 9 participants.
The verdict
NCT02270866, a NA study, has completed, sponsored by Scion NeuroStim.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This is a single site, open label study with a single arm designed to assess the feasibility of use of caloric vestibular stimulation (CVS) in patients with post-stroke aphasia. CVS is delivered via a portable, non-invasive device. Both language and movement assessments are made.
Interventions
- DEVICE TNM Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02270866
The ClinicalTrials.gov registry entry for NCT02270866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scion NeuroStim, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TNM Device is the first listed.
NCT02270866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02270866 about?
NCT02270866 is a clinical study titled "Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia". This is a single site, open label study with a single arm designed to assess the feasibility of use of caloric vestibular stimulation (CVS) in patients with post-stroke aphasia. CVS is delivered via a portable, non-invasive device. Both language and movement assessments are made.
What is the current status of trial NCT02270866?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2014-10. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02270866?
The interventions under investigation include: TNM Device (DEVICE).
Who is sponsoring clinical trial NCT02270866?
This trial is sponsored by Scion NeuroStim, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.